Diagnosis and Management of Hypophosphatasia: Improving Patient Outcomes
Diagnosis and Management of Hypophosphatasia: Improving Patient Outcomes
CLICK "BEGIN" TO EVALUATE SESSIONS, CLAIM CME, AND PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION.
Target Audience
This continuing medical education activity should be of substantial interest to endocrinologists and endocrine fellows, pediatric endocrinologists and pediatric endocrine fellows, and other healthcare professionals caring for patients with metabolic bone disorders.
Learning Objectives
Upon completion of this educational activity, learners will be better able to:
- Describe the role of alkaline phosphatase and discuss the genetic underpinnings of hypophosphatasia
- Describe the skeletal and non- skeletal manifestations of hypophosphatasia
- Apply recently approved treatment option in perinatal, infantile and juvenile-onset hypophosphatasia
- Management of ongoing treatment of patients with hypophosphatasia
Additional Information
Attachment | Size |
---|---|
![]() | 2.81 MB |
Program Director
DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.
The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
Available Credit
- 2.50 AMA PRA Category 1 Credits™
- 2.50 CME Certificate of Participation